Employees: 01 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 2007-06-01 (18 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: REMIRE MONTJOLY (97354), Guyane
MEDITEC GUYANE : revenue, balance sheet and financial ratios
MEDITEC GUYANE is a French company
founded 18 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in REMIRE MONTJOLY (97354),
this company of category PME
shows in 2020 a revenue of 422 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - MEDITEC GUYANE (SIREN 498204890)
Indicator
2020
2019
Revenue
422 397 €
448 324 €
Net income
11 801 €
14 813 €
EBITDA
11 901 €
12 451 €
Net margin
2.8%
3.3%
Revenue and income statement
In 2020, MEDITEC GUYANE achieves revenue of 422 k€. Slight decline of -6% vs 2019. After deducting consumption (281 k€), gross margin stands at 142 k€, i.e. a rate of 34%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 12 k€, representing 2.8% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 12 k€, i.e. 2.8% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2020)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
422 397 €
Gross margin (2020)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
141 833 €
EBITDA (2020)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
11 901 €
EBIT (2020)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
12 560 €
Net income (2020)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
11 801 €
EBITDA margin (2020)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
2.8%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 42%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 6.6 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 2.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
Debt ratio (2020)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
42.256%
Financial autonomy (2020)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
52.461%
Cash flow / Revenue (2020)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
2.674%
Repayment capacity (2020)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
6.618
Asset age ratio (2020)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
Debt ratio
0.401
42.256
Financial autonomy
72.637
52.461
Repayment capacity
0.0
6.618
Cash flow / Revenue
2.795%
2.674%
Sector positioning
Debt ratio
42.262020
2019
2020
Q1: 0.0
Med: 9.34
Q3: 68.4
Average+37 pts over 2 years
In 2020, the debt ratio of MEDITEC GUYANE (42.26) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
52.46%2020
2019
2020
Q1: 14.08%
Med: 36.68%
Q3: 58.19%
Good-8 pts over 2 years
In 2020, the financial autonomy of MEDITEC GUYANE (52.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
6.62 years2020
2019
2020
Q1: 0.0 years
Med: 0.01 years
Q3: 1.74 years
Watch+50 pts over 2 years
In 2020, the repayment capacity of MEDITEC GUYANE (6.62) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 333.13. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 5.6x. Operating income very largely covers interest expenses: high safety margin.
Liquidity ratio (2020)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
333.132
Interest coverage (2020)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
5.647
Liquidity indicators evolution MEDITEC GUYANE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
Liquidity ratio
282.79
333.132
Interest coverage
6.08
5.647
Sector positioning
Liquidity ratio
333.132020
2019
2020
Q1: 139.76
Med: 208.19
Q3: 335.17
Good+8 pts over 2 years
In 2020, the liquidity ratio of MEDITEC GUYANE (333.13) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
5.65x2020
2019
2020
Q1: 0.0x
Med: 0.25x
Q3: 3.9x
Excellent
In 2020, the interest coverage of MEDITEC GUYANE (5.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 38 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 66 days. Favorable situation: supplier credit is longer than customer credit by 28 days. Inventory turnover is 84 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 111 days of revenue, i.e. 131 k€ to permanently finance.
Operating WCR (2020)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
130 592 €
Customer credit (2020)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
38 j
Supplier credit (2020)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
66 j
Inventory turnover (2020)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
84 j
WCR in days of revenue (2020)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
111 j
WCR and payment terms evolution MEDITEC GUYANE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
Operating WCR
123 195 €
130 592 €
Inventory turnover (days)
71
84
Customer payment term (days)
33
38
Supplier payment term (days)
47
66
Positioning of MEDITEC GUYANE in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Based on 124 transactions of similar company sales
(all years),
the value of MEDITEC GUYANE is estimated at
33 115 €
(range 17 352€ - 104 072€).
With an EBITDA of 11 901€, the sector multiple of 0.7x is applied.
The price/revenue ratio is 0.21x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2020
124 transactions
17k€33k€104k€
33 115 €Range: 17 352€ - 104 072€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
11 901 €×0.7x
Estimation8 377 €
3 960€ - 30 489€
Revenue Multiple30%
422 397 €×0.21x
Estimation89 960 €
48 783€ - 272 490€
Net Income Multiple20%
11 801 €×0.8x
Estimation9 695 €
3 690€ - 35 404€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare MEDITEC GUYANE with other companies in the same sector:
Yes, MEDITEC GUYANE generated a net profit of 12 k€ in 2020.
Where is the headquarters of MEDITEC GUYANE ?
The headquarters of MEDITEC GUYANE is located in REMIRE MONTJOLY (97354), in the department Guyane.
Where to find the tax return of MEDITEC GUYANE ?
The tax return of MEDITEC GUYANE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does MEDITEC GUYANE operate?
MEDITEC GUYANE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart